Parenclitic networks for predicting ovarian cancer
Open Access
- 27 April 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (32) , 22717-22726
Abstract
Parenclitic networks for predicting ovarian cancer Parenclitic networks for predicting ovarian cancerKeywords
This publication has 35 references indexed in Scilit:
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent ScalabilityPLOS ONE, 2014
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profilingOncogene, 2012
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial SpecimensCancer Prevention Research, 2011
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy AlgorithmBritish Journal of Cancer, 2011
- HE4 as a biomarker for ovarian and endometrial cancer managementExpert Review of Molecular Diagnostics, 2009
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cellsJournal of Clinical Investigation, 2008
- Mapping the Cancer GenomeScientific American, 2007
- Expression of a Fibroblast Growth Factor–Binding Protein during the Development of Adenocarcinoma of the Pancreas and ColonCancer Research, 2006
- Effects of Sample Size on Kernel Home Range EstimatesThe Journal of Wildlife Management, 1999